BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15192036)

  • 1. Caveolae and caveolins in the cardiovascular system.
    Gratton JP; Bernatchez P; Sessa WC
    Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
    Drab M; Verkade P; Elger M; Kasper M; Lohn M; Lauterbach B; Menne J; Lindschau C; Mende F; Luft FC; Schedl A; Haller H; Kurzchalia TV
    Science; 2001 Sep; 293(5539):2449-52. PubMed ID: 11498544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin, caveolae, and endothelial cell function.
    Frank PG; Woodman SE; Park DS; Lisanti MP
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1161-8. PubMed ID: 12689915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biology. Life without caveolae.
    Parton RG
    Science; 2001 Sep; 293(5539):2404-5. PubMed ID: 11577223
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
    Rath G; Dessy C; Feron O
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolae: a once-elusive structure gets some respect.
    Marx J
    Science; 2001 Nov; 294(5548):1862-5. PubMed ID: 11729300
    [No Abstract]   [Full Text] [Related]  

  • 9. Caveolins and the regulation of endothelial nitric oxide synthase in the heart.
    Feron O; Balligand JL
    Cardiovasc Res; 2006 Mar; 69(4):788-97. PubMed ID: 16483868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation and integration: roles played by caveolae and caveolins in the cardiovascular system.
    Fleming I
    Cardiovasc Res; 2006 Mar; 69(4):784-7. PubMed ID: 16464441
    [No Abstract]   [Full Text] [Related]  

  • 11. Caveolae, lipid rafts, and vascular disease.
    Li XA; Everson WV; Smart EJ
    Trends Cardiovasc Med; 2005 Apr; 15(3):92-6. PubMed ID: 16039968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis.
    Sbaa E; Frérart F; Feron O
    Trends Cardiovasc Med; 2005 Jul; 15(5):157-62. PubMed ID: 16165011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.
    Xu Y; Buikema H; van Gilst WH; Henning RH
    Eur J Pharmacol; 2008 May; 585(2-3):256-60. PubMed ID: 18423600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory mechanisms of hepatic microcirculation.
    Oda M; Yokomori H; Han JY
    Clin Hemorheol Microcirc; 2003; 29(3-4):167-82. PubMed ID: 14724338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of caveolin-1 in cardiovascular regulation.
    Rahman A; Swärd K
    Acta Physiol (Oxf); 2009 Feb; 195(2):231-45. PubMed ID: 18826501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular signaling through cholesterol-rich domains: implications in hypertension.
    Callera GE; Montezano AC; Yogi A; Tostes RC; Touyz RM
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):90-104. PubMed ID: 17293683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease.
    Das M; Das DK
    Ann Med; 2012 Sep; 44(6):530-41. PubMed ID: 21651441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do caveolins regulate cells by actions outside of caveolae?
    Head BP; Insel PA
    Trends Cell Biol; 2007 Feb; 17(2):51-7. PubMed ID: 17150359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
    Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
    Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells.
    Kim HP; Wang X; Galbiati F; Ryter SW; Choi AM
    FASEB J; 2004 Jul; 18(10):1080-9. PubMed ID: 15226268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.